companies innovating obesity treatment glp-1 drugs 2025 Market Size to Hit USD 66.57 Billion by 2035 Pharma Giants Bet on Next-Generation

Perfect B uses a cycle-based model with no subscription required

Effect of semaglutide on insulin dose reduction in adults with type 1 diabetes and obesity using automated insulin delivery systems: ADJUST-T1D post hoc analysis

Why is GHK-Cu sold as an injectable vial if topical has the evidence

By Gabe Sanders PhD, NSCA-CSCS When it comes to muscle building and recovery, peptides have garnered significant attention in recent years

This study highlights the critical role of protrusion-derived EVs in the transport of functional proteins such as Rac1

Membranes under the magnetic lens: a dive into the diverse world of membrane protein structures using cryo-EM